KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
-13.33%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$463M
AUM Growth
+$463M
(-24%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-12.29%
Top 10 Holdings %
Top 10 Hldgs %
40.7%
Holding
140
New
5
Increased
9
Reduced
56
Closed
10
Top Buys
Top Sells
| 1 |
Citizens Financial Group
CFG
|
$11.7M |
| 2 |
CommScope
COMM
|
$11.4M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.45M |
| 4 |
AGN
Allergan plc
AGN
|
$5.95M |
| 5 |
Bright Horizons
BFAM
|
$5.66M |
Sector Composition
| 1 | Technology | 23.58% |
| 2 | Healthcare | 18.17% |
| 3 | Financials | 18.09% |
| 4 | Consumer Discretionary | 11.74% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$324B
| $6.34M | 1.37% |
58,297
-10,003
| -15% | -$1.09M |
|
27
JPMorgan Chase
JPM
$829B
| $6.31M | 1.36% |
64,610
-5,400
| -8% | -$527K |
|
28
Alphabet (Google) Class C
GOOG
$2.58T
| $6M | 1.3% |
5,792
-135
| -2% | -$140K |
|
29
Cisco
CSCO
$274B
| $5.94M | 1.28% |
137,076
-23,200
| -14% | -$1.01M |
|
|
CELG
30
DELISTED
Celgene Corp
CELG
| $4.91M | 1.06% |
76,572
-57,201
| -43% | -$3.67M |
|
31
Schlumberger
SLB
$55B
| $4.9M | 1.06% |
135,741
-73,712
| -35% | -$2.66M |
|
32
Applied Materials
AMAT
$128B
| $3.24M | 0.7% |
98,805
| – | – |
|
33
Aflac
AFL
$57.2B
| $3.06M | 0.66% |
67,086
-4,532
| -6% | -$207K |
|
34
Procter & Gamble
PG
$368B
| $2.94M | 0.63% |
31,955
-7,700
| -19% | -$708K |
|
|
35
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.13M | 0.46% |
5,711
-19,949
| -78% | -$7.45M |
|
36
Vertex Pharmaceuticals
VRTX
$100B
| $1.86M | 0.4% |
11,202
-125
| -1% | -$20.7K |
|
37
Halliburton
HAL
$19.4B
| $1.85M | 0.4% |
69,575
-68,975
| -50% | -$1.83M |
|
|
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.61M | 0.35% |
27,574
| – | – |
|
|
AGN
39
DELISTED
Allergan plc
AGN
| $1.51M | 0.33% |
11,273
-44,536
| -80% | -$5.95M |
|
40
Verizon
VZ
$186B
| $1.51M | 0.33% |
26,775
-5,000
| -16% | -$281K |
|
41
AbbVie
ABBV
$372B
| $1.49M | 0.32% |
16,145
-8,900
| -36% | -$821K |
|
42
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.47M | 0.32% |
1,165
-525
| -31% | -$662K |
|
43
Gilead Sciences
GILD
$140B
| $1.42M | 0.31% |
22,705
-8,000
| -26% | -$500K |
|
44
B&G Foods
BGS
$361M
| $1.31M | 0.28% |
45,200
-17,800
| -28% | -$515K |
|
45
DuPont de Nemours
DD
$32.2B
| $1.18M | 0.25% |
22,000
-575
| -3% | -$30.8K |
|
46
Exxon Mobil
XOM
$487B
| $1.12M | 0.24% |
16,431
-6,264
| -28% | -$427K |
|
|
TWO.PRE
47
DELISTED
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
| $1.05M | 0.23% |
45,750
-23,300
| -34% | -$534K |
|
48
Pfizer
PFE
$141B
| $915K | 0.2% |
20,960
| – | – |
|
49
VeriSign
VRSN
$25.5B
| $898K | 0.19% |
6,058
| – | – |
|
50
Microsoft
MSFT
$3.77T
| $877K | 0.19% |
8,638
-1,434
| -14% | -$146K |
|